SNYR vs PRGO vs HIMS vs NTRP vs CLAR

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -18. 6% for Synergy CHC Corp. (SNYR). Synergy CHC Corp. (SNYR) offers the better valuation at 1. 4x trailing P/E, making it the more compelling value choice. Analysts rate Perrigo Company plc (PRGO) a "Hold" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Synergy CHC Corp.

(SNYR) is the cheapest at 1. 4x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -96. 2% for NextTrip, Inc. (NTRP). Over 10 years, the gap is even starker: HIMS returned +161. 9% versus NTRP's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Synergy CHC Corp.

(SNYR) is the lower-risk stock at 0. 79β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 205% more volatile than SNYR relative to the S&P 500. On balance sheet safety, Clarus Corporation (CLAR) carries a lower debt/equity ratio of 6% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -18. 6% for Synergy CHC Corp. (SNYR). On earnings-per-share growth, the picture is similar: Synergy CHC Corp. grew EPS 297. 2% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Synergy CHC Corp.

(SNYR) is the more profitable company, earning 6. 1% net margin versus -20. 2% for NextTrip, Inc. — meaning it keeps 6. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SNYR leads at 16. 7% versus -1677. 9% for NTRP. At the gross margin level — before operating expenses — SNYR leads at 67. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

6x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 45. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLAR: 73. 0% to $5. 00.

In this comparison, PRGO (9.

8% yield), CLAR (3. 5% yield) pay a dividend. SNYR, HIMS, NTRP do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

18), 9. 8% yield). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRGO: -77. 7%, HIMS: +161. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SNYR (Healthcare) and PRGO (Healthcare) and HIMS (Healthcare) and NTRP (Consumer Cyclical) and CLAR (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SNYR is a small-cap deep-value stock; PRGO is a small-cap income-oriented stock; HIMS is a small-cap high-growth stock; NTRP is a small-cap quality compounder stock; CLAR is a small-cap income-oriented stock. PRGO, CLAR pay a dividend while SNYR, HIMS, NTRP do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.